{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:18:32Z","timestamp":1791613112846,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3781-1","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:04:05Z","timestamp":1550225045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy"],"prefix":"10.1186","volume":"19","author":[{"given":"Claris","family":"Shoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delson","family":"Chikobvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"3781_CR1","doi-asserted-by":"crossref","unstructured":"Hoffmann CJ, Charalambous S, Thio CL, Martin DJ, Pemba L, et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS. 2010;21:1301\u20138. [PubMed: 17545706]","DOI":"10.1097\/QAD.0b013e32814e6b08"},{"key":"3781_CR2","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","volume":"286","author":"AN Phillips","year":"2001","unstructured":"Phillips AN, Staszewski S, Weber R, Kirk O, Francidi P, Miller V, Vernazza P, Lundgren JD, Ledergerber B. HIV viral response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 2001;286:2560\u20137.","journal-title":"JAMA"},{"key":"3781_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/COH.0000000000000348","volume":"12","author":"N Ford","year":"2017","unstructured":"Ford N, Mentjes G, Victoria M, Greene G, Chiller T. The evolving role of CD4 cell count in HIV care. Curr Opin HIV AIDS. 2017;12:123\u20138. \n                    https:\/\/doi.org\/10.1097\/COH.0000000000000348\n                    \n                  .","journal-title":"Curr Opin HIV AIDS"},{"issue":"16","key":"3781_CR4","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1097\/QAD.0000000000000446","volume":"28","author":"L Salazar-Vizcaya","year":"2014","unstructured":"Salazar-Vizcaya L, Keiser O, Technau K, Davies M, Haas AD, Blaser N, Cox V, Eley B, Rabie H, Moultrie H, Giddy J, Wood R, Egger M, Estill J. Viral load versus CD4 monitoring and a 5-year outcomes of ART in HIV-positive children in southern Africa: cohort-based modelling study. AIDS. 2014;28(16):2451\u201360.","journal-title":"AIDS"},{"issue":"8","key":"3781_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/archinte.160.8.1134","volume":"160","author":"P Erb","year":"2000","unstructured":"Erb P, Batlegay M, Zimmerli W, et al. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency virus \u2013 infected cohort. Arch Intern Med. 2000;160(8):1134\u201340. \n                    https:\/\/doi.org\/10.1001\/archinte.160.8.1134\n                    \n                  .","journal-title":"Arch Intern Med"},{"key":"3781_CR6","doi-asserted-by":"publisher","unstructured":"Brennan AT, Maskew M, Sanne I, and Matthew P Fox MP. The interplay between CD4 cell count, viral load suppression and duration of ART on mortality in a resource-limited setting. Trop Med Int Health. 2013;18(5):619\u201331. \n                    https:\/\/doi.org\/10.1111\/tmi.12079\n                    \n                  .","DOI":"10.1111\/tmi.12079"},{"key":"3781_CR7","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1086\/597617","volume":"199","author":"ER Brown","year":"2009","unstructured":"Brown ER, Otieno P, Mbori-Ngacha DA, Farquhar C, Obimbo EM, Nduati R, Overbaugh J, John-Steward GC. Comparison of CD4 cell count, viral load and other markers for the prediction of mortality among HIV-1 \u2013 infected Kenyan pregnant women. J Infect Dis. 2009;199:1292\u2013300.","journal-title":"J Infect Dis"},{"key":"3781_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1086\/341466","volume":"186","author":"V Miller","year":"2002","unstructured":"Miller V, Phillips AN, Clotet B, Mocroft A, Ledergerber B, Kirk O, Ormaasen V, Gargalianos-Kakolyris P, Vella S, Lundgren JD. Association of virus load, CD4 cell count and treatment with clinical progression in human immunodeficiency virus-infected patients with very lo CD4 cell counts. J Infect Dis. 2002;186:189\u201397.","journal-title":"J Infect Dis"},{"issue":"4","key":"3781_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1590\/S0102-311X2013000800017","volume":"29","author":"R Vasconcellos","year":"2013","unstructured":"Vasconcellos R, Oliveira C, Shimakura SE, Campos DP, Victoriano FP, Ribeiro SR, Veloso VG, Grinsztejn B, Carvalho M. Multistate models for defining degrees of chronicity related to HIV-infected patient therapy adherence. CadSaude Publica, Rio de Janeiro. 2013;29(4):801\u201311.","journal-title":"CadSaude Publica, Rio de Janeiro"},{"key":"3781_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/s0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384:258\u201371. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(14)60164-1\n                    \n                   Accessed 11 Jan 2018.","journal-title":"Lancet"},{"issue":"3","key":"3781_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1468-1293.2005.00285.x","volume":"6","author":"CA Dounelly","year":"2005","unstructured":"Dounelly CA, Bartley LM, Ghani AC, Le Fevre AM, Kwong GP, Cowling BJ, van Sighem AI, de Wolf F, Rode RA, Anderson RM. Gender differences in HIV-1 RNA viral loads. HIV Med. 2005;6(3):170\u20138.","journal-title":"HIV Med"},{"key":"3781_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4236\/wja.2014.42020","volume":"4","author":"M Hasibi","year":"2014","unstructured":"Hasibi M, Hajiabdolbaghi M, Hamzelon S, Sardashti S, Forough M, Jozani ZB, Alinaghi SAS. Impact of age on CD4 response to combination antiretroviral therapy: a study in Tehran, Iran. World J AIDS. 2014;4:156\u201362.","journal-title":"World J AIDS"},{"key":"3781_CR13","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1016\/j.ijid.2013.02.023","volume":"17","author":"S Metallidis","year":"2013","unstructured":"Metallidis S, Tsachouridou O, Skoura L, Zebekakis P, Chrysanthidis T, Pilalas D, Bakaimi I, Kollaras P, Germanidis G, Tsiara A, Galanos A, Malisiovas N, Nikolaidis P. Older HIV-infected patients\u2014an underestimated population in northern Greece: epidemiology, risk of disease progression and death. Int J Infect Dis. 2013;17:e883\u201391. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2013.02.023\n                    \n                  .","journal-title":"Int J Infect Dis"},{"key":"3781_CR14","volume-title":"What\u2019s new in treatment monitoring: Viral load and CD4 cell testing, July 2017","author":"WHO","year":"2017","unstructured":"WHO. What\u2019s new in treatment monitoring: Viral load and CD4 cell testing, July 2017. Geneva: World Health Organisation; 2017. WHO\/HIV\/2017.22"},{"issue":"2","key":"3781_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3855\/jidc.2875","volume":"7","author":"S Ghadha","year":"2013","unstructured":"Ghadha S, Bhalla P, Jha AK, Gautam H, Saini S, Aneradha S. Diseases progression and antiretroviral therapy in newly seropositive HIV subjects in a tertiary care hospital in North India. J Infect Dev Ctries. 2013;7(2):110\u20135.","journal-title":"J Infect Dev Ctries"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3781-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3781-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3781-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:06:47Z","timestamp":1581707207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3781-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3781"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3781-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Permission to use the secondary data was granted by the Ethics Committee of the University of Venda in 2013. Names of participants were not included in the data set.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"169"}}